ANL 11.12 Increased By ▲ 0.53 (5%)
ASC 9.65 Increased By ▲ 0.18 (1.9%)
ASL 11.26 Increased By ▲ 0.31 (2.83%)
AVN 74.41 Increased By ▲ 5.21 (7.53%)
BOP 5.77 Decreased By ▼ -0.09 (-1.54%)
CNERGY 5.28 Increased By ▲ 0.14 (2.72%)
FFL 6.91 Increased By ▲ 0.15 (2.22%)
FNEL 6.05 Increased By ▲ 0.14 (2.37%)
GGGL 11.94 Increased By ▲ 0.76 (6.8%)
GGL 16.13 Increased By ▲ 1.13 (7.53%)
GTECH 9.11 Increased By ▲ 0.42 (4.83%)
HUMNL 6.54 Increased By ▲ 0.24 (3.81%)
KEL 2.52 Increased By ▲ 0.03 (1.2%)
KOSM 3.01 Increased By ▲ 0.09 (3.08%)
MLCF 26.30 Decreased By ▼ -0.20 (-0.75%)
PACE 3.04 Increased By ▲ 0.04 (1.33%)
PIBTL 5.99 Increased By ▲ 0.14 (2.39%)
PRL 16.60 Increased By ▲ 0.80 (5.06%)
PTC 7.50 Increased By ▲ 0.15 (2.04%)
SILK 1.37 No Change ▼ 0.00 (0%)
SNGP 25.80 Decreased By ▼ -0.10 (-0.39%)
TELE 10.75 Increased By ▲ 0.53 (5.19%)
TPL 9.30 Increased By ▲ 0.60 (6.9%)
TPLP 16.65 Increased By ▲ 1.27 (8.26%)
TREET 28.90 Increased By ▲ 0.80 (2.85%)
TRG 78.40 Increased By ▲ 1.82 (2.38%)
UNITY 22.21 Increased By ▲ 0.72 (3.35%)
WAVES 12.95 Increased By ▲ 0.05 (0.39%)
WTL 1.54 Increased By ▲ 0.06 (4.05%)
YOUW 5.10 Increased By ▲ 0.31 (6.47%)
BR100 4,164 Increased By 7.5 (0.18%)
BR30 14,902 Increased By 371.2 (2.55%)
KSE100 42,013 Increased By 62.3 (0.15%)
KSE30 15,913 Increased By 10.4 (0.07%)

Thermo Fisher Scientific Inc said on Monday its COVID-19 diagnostic tests can accurately detect the new coronavirus variant Omicron that has made several countries to shut their borders.

The World Health Organisation (WHO) last week classified the Omicron variant as a SARS-CoV-2 "variant of concern," saying it may spread more quickly than other forms.

Thermo Fisher's TaqPath COVID-19 assays can report accurate results even in the case where one of the gene targets is impacted by a mutation, the company said in a statement.

"This assay can be used not only to successfully detect COVID-19 but_ it also be used as a proxy for the variant," Mark Stevenson, chief operating officer at Thermo Fisher Scientific, said in an interview.

Stevenson said this is the only COVID-19 diagnostic test authorized by the US Food and Drug Administration and currently in use by health systems that can be used to indicate if a case is caused by the Omnicron variant.

Test samples must still be sent to a lab for sequencing to confirm that the case was caused by Omnicron and not another variant with similar features, such as the Alpha variant, he said.

Omicron, which was first detected in Southern Africa, has now been confirmed in Australia, Belgium, Botswana, Britain, Denmark, Germany, Hong Kong, Israel, Italy, the Netherlands, France, South Africa, and the United States' neighbor to the north, Canada.

The WHO said it was working with technical experts to understand the potential impact of the variant on existing countermeasures against COVID-19, including vaccines.

Comments

Comments are closed.